ISSN 2424-8592

E-ISSN 2424-9106

Current Issue

Volume 11,Issue 7

Fall 2026

View This Issues

Advances in Precision Medicine

Editor-in-Chief: Piccaluga Pier Paolo

Advances in Precision Medicine (APM) brings together all aspects of the rapidly growing field of personalized/precision medicine. Biomarkers are a key focus of APM’s scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmacodynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.

Aims & Scope

Aims and Scope

Aims

Advances in Precision Medicine (APM) is an international Open Access journal dedicated to advancing the rapidly growing field of personalized and precision medicine. The journal aims to provide a high-quality, peer-reviewed platform for the publication and dissemination of original research articles and review articles that contribute to the fundamental understanding, development, and clinical application of precision medicine. By promoting open and rapid exchange of knowledge, the journal seeks to foster innovation and support the translation of research findings into improved patient care and individualized treatment strategies.

Scope

The journal covers all aspects of precision medicine, encompassing theoretical, computational, experimental, and clinical research. Biomarkers are a key focus of APM's scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmacodynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.

Topics of interest include, but are not limited to:

  • Stratification biomarkers and companion diagnostics

  • Pharmacodynamic biomarkers and target engagement

  • Safety biomarkers and early detection of adverse effects

  • Disease biomarkers for diagnosis, prognosis, and surrogate endpoints

  • Genomic and molecular profiling

  • Targeted therapies and individualized treatment strategies

  • Clinical implementation of precision medicine

  • Computational and bioinformatics approaches in precision medicine

  • Emerging topics at the intersection of precision medicine and related fields

Article Types

The journal publishes original research articles, review articles, and other high-quality contributions that advance the field of precision medicine.

Open Access

All articles are published under an Open Access model, ensuring free and unrestricted access to readers worldwide and maximizing the impact and visibility of published research.

Back to top